Literature DB >> 14694354

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.

Christine Duarte1, Richard Alonso, Nicole Bichet, Caroline Cohen, Philippe Soubrié, Marie-Hélène Thiébot.   

Abstract

It has been shown previously that the selective cannabinoid CB1 receptor antagonist, rimonabant (SR141716), reduced the intake of palatable food as well as the self-administration of several drugs of abuse, suggesting that endocannabinoid systems play a role in brain reward function. The present study investigated whether a cannabinoid step was involved in food-seeking behavior induced by explicit stimuli, using an operant reinstatement procedure in rats. Experimental sessions consisted of a 15-min food rewarded period, followed by a 45-min extinction period. Rimonabant did not affect the response reinstatement induced by noncontingent delivery of food pellets, but prevented (0.03-0.3 mg/kg) the potentiation by quinelorane, a dopamine D3 receptor-preferring agonist, of food-seeking behavior. A possible link between cannabinoid processes and D3- and/or D2-mediated dopaminergic transmission was further investigated by studying Fos protein expression in cortico-limbic structures in D3 (D3-/-) and D2 (D2-/-) knockout mice. Rimonabant (10 mg/kg) increased Fos immunoreactivity in the prefrontal cortex (pFCortex) and in the shell but not the core of the nucleus accumbens (NAcc). Fos induction by this dose of rimonabant was not seen in mice lacking CB1 receptors, providing clear evidence for the involvement of CB1 receptors. In the NAcc shell, the effect of rimonabant was suppressed in D3-/-, but remained unchanged in D2-/- mice. In contrast, Fos expression by rimonabant in the pFCortex was impervious to D2 or D3 receptor deletion. In conclusion, these data indicate first that rimonabant prevented the enhancement by quinelorane of the appetitive value of food pellets unexpectedly delivered during extinction and second that rimonabant effects might involve D3 receptor-mediated processes. Overall, these results are consistent with the notion that endocannabinoid functions control brain reward processes and in particular the capacity of explicit stimuli to precipitate food-seeking behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694354     DOI: 10.1038/sj.npp.1300370

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  12 in total

1.  Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors.

Authors:  Susana Ramiro-Fuentes; Emilio Fernandez-Espejo
Journal:  Psychopharmacology (Berl)       Date:  2010-12-03       Impact factor: 4.530

2.  A behavioral and pharmacological characterization of palatable diet alternation in mice.

Authors:  Catherine F Moore; Gabrielle S Schlain; Samantha Mancino; Valentina Sabino; Pietro Cottone
Journal:  Pharmacol Biochem Behav       Date:  2017-10-31       Impact factor: 3.533

3.  Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of μ-opioid receptors and on dopamine axons in the mouse nucleus accumbens.

Authors:  Diane A Lane; June Chan; Carl R Lupica; Virginia M Pickel
Journal:  Synapse       Date:  2010-12       Impact factor: 2.562

4.  Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.

Authors:  Virgina M Pickel; Jane Chan; Christopher S Kearn; Kenneth Mackie
Journal:  J Comp Neurol       Date:  2006-03-20       Impact factor: 3.215

5.  CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.

Authors:  M Sabrina Spano; Liana Fattore; Gregorio Cossu; Serena Deiana; Paola Fadda; Walter Fratta
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

Review 6.  Cannabinoids in eating disorders and obesity.

Authors:  Francisco Arias Horcajadas
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

Review 7.  The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.

Authors:  Sunila G Nair; Tristan Adams-Deutsch; David H Epstein; Yavin Shaham
Journal:  Prog Neurobiol       Date:  2009-06-02       Impact factor: 11.685

Review 8.  Rationale and consequences of reclassifying obesity as an addictive disorder: neurobiology, food environment and social policy perspectives.

Authors:  Patricia J Allen; Payal Batra; Brenda M Geiger; Tara Wommack; Cheryl Gilhooly; Emmanuel N Pothos
Journal:  Physiol Behav       Date:  2012-05-11

9.  Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.

Authors:  E L Nurmi; S L Spilman; F Whelan; L L Scahill; M G Aman; C J McDougle; L E Arnold; B Handen; C Johnson; D G Sukhodolsky; D J Posey; L Lecavalier; K A Stigler; L Ritz; E Tierney; B Vitiello; J T McCracken
Journal:  Transl Psychiatry       Date:  2013-06-25       Impact factor: 6.222

10.  Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli.

Authors:  Daniela Laricchiuta; Alessandra Musella; Silvia Rossi; Diego Centonze
Journal:  Front Behav Neurosci       Date:  2014-05-19       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.